NuVasive, Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (41)

Latest Posts

About This Stock More About This Stock
Canaccord Says Sell NuVasive On Deal Speculation Rally, Buy Smith & Nephew
Article By: The Fly
Monday, February 11, 2019 3:00 PM EDT
The analyst does not find a potential of NuVasive acquisition by Smith & Nephew "to be compelling". A deal could be disruptive to Smith & Nephew's turnaround in both commercial performance and investor sentiment.
In this article: NUVA, SNN
Read
3 Stocks To Tap The Minimally-invasive Surgery Market Boom
Article By: Zacks Investment Research
Thursday, June 28, 2018 10:47 PM EDT
The U.S. Medical Device industry is likely to be worth $173 billion by 2019.
In this article: MDT, NUVA, ISRG
Read
JANA’s Barry Rosenstein Is Slashing HPE; NUVA; But Buying EQT
Article By: TipRanks
Thursday, November 23, 2017 11:15 AM EDT
Jana Partners LLC has consistently underperformed against average hedge fund portfolios and S&P 500 benchmarks over the past few quarters.
In this article: HPE, NUVA, EQT
Read
Medtronic Beats Q1 Earnings, Revenues Closely In-Line
Article By: Zacks Investment Research
Thursday, August 25, 2016 9:00 PM EDT
Medtronic plc reported financial results for first-quarter fiscal 2017. Adjusted earnings per share in the reported quarter came in at $1.03, 2 cents ahead of the Zacks Consensus Estimate and up 1% year over year.
In this article: MDT, NUVA, QDEL, GWPH
Read
E Mid Cap Best & Worst Report - June 8, 2016
Article By: E.B. Capital Markets
Wednesday, June 8, 2016 9:07 AM EDT
The average mid cap stock in our coverage is trading -19.78% below its 52 week high, 5.95% above its 200 dma, has 6.49 days to cover held short, and is expected to grow its EPS by 16.3% in the coming year.
In this article: AIZ, BDC, CNC, GIS, NEU, NJR, PDS, POL, RBA, RES, RGC, TEN, TUP, TYL, NUVA, CDNS, ENTG, LOCK
Read

PARTNER HEADLINES

Latest Tweets for $NUVA

No tweets yet!